Portfolio Lab

RadNet, Inc.

  • Stock
  • Ticker RDNT
  • ISIN US7504911022
  • Nasdaq

Health care · Health care services · USA

$69.71 +0.29%
Close of 20 Nov 2026
Open in backtest

Performance, volatility and drawdowns of RadNet, Inc. since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

RDNTGlobal equities (VT)

$10,000 grew to $114,279. Global equities (VT): $29,042.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −73.4% in 03/2020, measured from the peak in 02/2020. It took 13 months to get back to the old peak.

1-year return
−12.0%
5-year return p.a.
+19.8%
10-year return p.a.
+27.6%
Volatility p.a.
46.5%
Largest decline
−73.4%

Financial statements

Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures

Quarter end12/202403/202506/202509/202512/202503/202606/202609/2026
Income statement
Revenue477471498523548576623638
Operating income25-24312728-243930
EBITDA6111676769218577
Net income5.3-38145.4-0.6-337.54.2
Earnings per share0.08-0.510.190.07-0.01-0.430.100.05
Balance sheet
Total assets3,2873,3363,5153,6653,7593,8854,2264,280
Liabilities2,1532,2002,3362,3512,4032,5332,8322,844
Equity9028989321,0591,0901,0811,0961,121
Cash740717833805767455726751
Long-term debt9929851,0771,0711,0641,0601,3021,294
Cash flow
Operating cash flow43411205384799491
Free cash flow43411205384799491

Value it:DCF calculatorMultiples calculator

Annual returns

Best year 2024 at +100.9%, weakest 2022 at −37.5%. 7 of 9 full years were positive. * partial year.

Quarterly reports

Filing date with the SEC and earnings per share of the quarter

DayEarnings per share
9 Nov 2026$0.05
10 Aug 2026$0.10
11 May 2026−$0.43
2 Mar 2026−$0.01
10 Nov 2025$0.07
11 Aug 2025$0.19
12 May 2025−$0.51
3 Mar 2025$0.08
12 Nov 2024$0.04
9 Aug 2024−$0.04
10 May 2024−$0.04
29 Feb 2024−$0.03

Key metrics

Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.

Valuation

Market cap
€5.0bn
Market cap in trading currency
$5.49bn
Enterprise value
$6.07bn
P/E
–
P/S
2.30
P/B
4.90
EV/Sales
2.54
EV/EBITDA
24.1
Earnings yield
–
FCF yield
6.3%

Results (last four quarters)

Revenue
$2.38bn
Gross profit
–
EBITDA
$252m
Net income
−$22.4m
Earnings per share
−$0.29
Revenue per share
$30.27
Revenue growth
+22.1%
Earnings growth
−23.3%

Profitability

Gross margin
–
Operating margin
3.1%
Net margin
-0.9%
Return on equity
-2.1%
Return on assets
-0.5%

Balance sheet and cash flow

Cash
$751m
Cash per share
$9.53
Financial debt
$1.33bn
Debt/equity %
118
Current ratio
1.49
Book value per share
$14.23
Operating cash flow
$348m
Free cash flow
$348m

Dividend

Dividend yield
0.00%
Dividend (12 months)
$0.00
Yield (12 months)
0.00%
Payout ratio
–
Ex-dividend date
–

Shares and trading

Shares outstanding
78.8m
Volume
593,591
Avg. volume 3 months
682,067
Relative volume
0.9

Price and technicals

Price
$69.71
1 day
+0.3%
52-week high
$84.48
52-week low
$51.87
Distance to 52-week high
−17.5%
Distance to 52-week low
+34.4%
Distance to 50-day line
−4.1%
Distance to 200-day line
+6.5%
RSI (14)
39
Volatility 1M
47.3%

Performance

1 week
−8.8%
1 month
−0.8%
3 months
−6.7%
6 months
+28.1%
YTD
−2.3%
1 year
−13.2%

Dates

Fiscal year end
31 Dec 2025
Most recent quarter
30 Sep 2026

Frequently asked questions

How has RDNT performed since 11/2016?

$10,000 grew to $114,279 by 20 Nov 2026, which is +27.6% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is RDNT?

Volatility was 46.5% per year, measured on monthly returns. The largest decline from a peak was −73.4%, with the low in 03/2020.

How does RDNT compare with a broad equity ETF?

Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, RDNT returned +27.6% at 46.5%. The correlation of monthly returns was 0.53; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Not investment advice. Metrics and financial statements calculated from the company's mandatory filings with the SEC, without guarantee; amounts in US dollars.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

RadNet, Inc. (RDNT): Return and risk | Portfolio Lab